Both in Diagnostics
Lantheus Holdings vs Celldex Therapeutics
Over the past year LNTH returned +97.0% and CLDX returned +20.2%; their daily moves had a correlation of 0.25.
LNTH +97.0% CLDX +20.2%Growth of $1, one year, split-adjusted
| Metric | LNTH | CLDX |
|---|---|---|
| Price | $99.74 | $31.49 |
| Market cap | $6.51B | $2.47B |
| Today | 0.00% | +1.25% |
| 1 month | −0.7% | −22.2% |
| 6 months | +33.9% | +3.9% |
| Year to date | +49.9% | +15.9% |
| 1 year | +93.8% | +24.7% |
| Revenue growth (YoY) | +2.7% | −97.0% |
| Gross margin | 62.3% | 100.0% |
| Net margin | 19.3% | −334104.5% |
| P/E (TTM) | 23.7× | — |
| Price / sales | 4.2× | 15,651.2× |
| Net cash | $22.2M | $717.6M |
| Dividend yield | — | — |
| Volatility (60d) | 25.4% | 47.6% |
| Short % of float | 6.3% | 12.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).